Global Kinetics and uMotif announce technology partnership for Parkinson’s trials
Posted:
2016-12-16 in Press Releases
Brandon Capital to lead Biomedical Translation Fund Consortium - major new Government initiative
Posted:
2016-12-13 in Press Releases
Management Team Strengthened as Auspherix Drives New Class of Antibacterials Towards the Clinic
Posted:
2016-11-17 in Press Releases
Osprey Introduces DyeVert PLUS at TCT
Posted:
2016-11-02 in Press Releases
Osprey Medical Inc. Releases Q3 2016 Cash Flow Results
Posted:
2016-10-14 in Press Releases
Global Kinetics Announces FDA Clearance for its Second Generation Parkinson’s Kinetigraph
Posted:
2016-09-22 in Press Releases
Global Kinetics Corporation Announces New President and CEO
Posted:
2016-08-30 in Press Releases
Osprey Medical Announces Oversubscribed A$28 Million Private Placement
Posted:
2016-08-04 in Press Releases
Osprey Medical Inc.4C Q2 Quarterly Cash Flow Report July '16
Posted:
2016-07-20 in Press Releases
Key Sales Milestones
Posted:
2016-07-07 in Press Releases
Auspherix Appoints Experienced Anti-Infectives Clinician to Scientific Advisory Board
Posted:
2016-07-04 in Press Releases
DyeVert Pilot Trial Results Presented at EuroPCR
Posted:
2016-05-20 in Press Releases
$4m start-up investment to accelerate drug discovery
Posted:
2016-03-23 in Press Releases
Osprey Medical Receives FDA Clearance for Key DyeVert™ System Claims
Posted:
2016-02-08 in Press Releases
Osprey Medical Inc. Quarterly Cash Flow Report
Posted:
2016-01-28 in Press Releases
Auspherix, as part of the BEAM Alliance, Signs Industry Declaration on Beating Antibiotic Resistance
Posted:
2016-01-21 in Press Releases
Brandon Capital Partners Expands into US, Opening Office in San Francisco Bay Area
Posted:
2016-01-08 in Press Releases